Get the Stockscreener App
29.72
4.50%
-1.40
After Hours:
29.72
Omnicell Inc stock is traded at $29.72, with a volume of 372.21K.
It is down -4.50% in the last 24 hours and down -6.72% over the past month.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.
See More
Previous Close:
$31.12
Open:
$31.03
24h Volume:
372.21K
Relative Volume:
0.73
Market Cap:
$1.37B
Revenue:
$1.15B
Net Income/Loss:
$23.09M
P/E Ratio:
59.44
EPS:
0.5
Net Cash Flow:
$89.18M
1W Performance:
-3.97%
1M Performance:
-6.72%
6M Performance:
-4.38%
1Y Performance:
-29.44%
1-Day Range:
$29.49
$31.48
1-Week Range:
$29.49
$31.68
52-Week Range:
$22.66
$55.74
Omnicell Inc Stock (OMCL) Company Profile
Name
Omnicell Inc
Sector
Industry
Phone
(877) 415-9990
Address
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
29.72 | 1.43B | 1.15B | 23.09M | 89.18M | 0.50 |
|
VEEV
Veeva Systems Inc
|
286.59 | 48.92B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
96.39 | 17.25B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
65.61 | 13.59B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
90.52 | 7.99B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.70 | 7.14B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-14-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-02-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-03-24 | Initiated | Barclays | Underweight |
| Nov-03-23 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-03-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Nov-03-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-11-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Sep-26-23 | Reiterated | Wells Fargo | Underweight |
| Aug-02-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-20-23 | Downgrade | Wells Fargo | Overweight → Underweight |
| Feb-27-23 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-03-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-09-22 | Initiated | BofA Securities | Buy |
| Jul-15-22 | Initiated | SVB Leerink | Mkt Perform |
| Dec-06-21 | Resumed | Wells Fargo | Overweight |
| Jun-09-21 | Initiated | JP Morgan | Neutral |
| May-24-21 | Initiated | BTIG Research | Buy |
| Feb-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Dec-03-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Feb-07-20 | Reiterated | Dougherty & Company | Buy |
| Nov-21-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-19 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-07-19 | Reiterated | Dougherty & Company | Buy |
| Jun-29-18 | Resumed | The Benchmark Company | Buy |
| Sep-05-17 | Reiterated | The Benchmark Company | Buy |
| Jul-28-17 | Reiterated | Dougherty & Company | Buy |
| Apr-21-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-19-17 | Initiated | Dougherty & Company | Buy |
| Dec-06-16 | Reiterated | The Benchmark Company | Buy |
| Jul-07-16 | Reiterated | FBR Capital | Outperform |
| Mar-21-16 | Reiterated | Topeka Capital Markets | Buy |
| Jan-07-16 | Initiated | The Benchmark Company | Buy |
| Nov-16-15 | Reiterated | Topeka Capital Markets | Buy |
| Oct-30-15 | Reiterated | FBR Capital | Outperform |
| Sep-28-15 | Upgrade | Sidoti | Neutral → Buy |
| Jul-31-15 | Reiterated | Topeka Capital Markets | Buy |
View All
Omnicell Inc Stock (OMCL) Latest News
Is Omnicell Inc. (OC9) stock a defensive play amid uncertaintyQuarterly Profit Report & High Conviction Buy Zone Alerts - newser.com
Should I hold or sell Omnicell Inc. stock in 2025Treasury Yields & Technical Analysis for Trade Confirmation - newser.com
Omnicell (NASDAQ:OMCL) Given Sell (D+) Rating at Weiss Ratings - MarketBeat
News impact scoring models applied to Omnicell Inc.Weekly Market Report & Low Drawdown Momentum Ideas - newser.com
Can Omnicell Inc. stock deliver sustainable ROETrade Analysis Summary & Free High Return Stock Watch Alerts - newser.com
Is Omnicell Inc. stock a defensive play in 2025Trade Volume Report & Weekly High Potential Stock Alerts - newser.com
Is Omnicell Inc. stock oversold or undervaluedPortfolio Performance Summary & Low Risk Entry Point Guides - newser.com
How Omnicell Inc. (OC9) stock reacts to stronger dollarInsider Selling & Fast Gain Swing Alerts - newser.com
Shareholders in Omnicell (NASDAQ:OMCL) are in the red if they invested five years ago - Yahoo Finance
Is Omnicell (OMCL) Stock Undervalued Right Now? - sharewise.com
Reasons to Add Omnicell Stock to Your Portfolio Right Now - Yahoo Finance
Omnicell Updates Bylaws for Enhanced Governance - TipRanks
Omnicell to Release Third Quarter 2025 Financial Results on October 30, 2025 - The Joplin Globe
Can technical indicators confirm Omnicell Inc.’s reversalPortfolio Risk Summary & Safe Capital Allocation Plans - newser.com
Hunter Perkins Capital Management LLC Buys Shares of 9,370 Omnicell, Inc. $OMCL - MarketBeat
U.S. Pharmacy Automation Devices Market to Witness Massive - openPR.com
How Omnicell Inc. stock performs after earningsJuly 2025 Catalysts & Weekly Momentum Picks - newser.com
Is Omnicell Inc. stock a safe haven assetProfit Target & Weekly Momentum Stock Picks - newser.com
Can machine learning forecast Omnicell Inc. recovery2025 Volatility Report & Verified Entry Point Signals - newser.com
Published on: 2025-10-05 04:57:53 - newser.com
Published on: 2025-10-05 04:12:10 - newser.com
Institutional scanner results for Omnicell Inc.Trade Analysis Summary & Comprehensive Market Scan Insights - newser.com
Will Omnicell Inc. stock gain from government policiesQuarterly Earnings Report & Technical Confirmation Trade Alerts - newser.com
Regression analysis insights on Omnicell Inc. performanceLayoff News & Reliable Breakout Forecasts - newser.com
Applying chart zones and confluence areas to Omnicell Inc.Trade Exit Report & AI Powered Market Trend Analysis - newser.com
Momentum divergence signals in Omnicell Inc. chartQuarterly Growth Report & Low Drawdown Trading Strategies - newser.com
Will Omnicell Inc. stock recover after recent dropGap Down & Fast Moving Stock Watchlists - newser.com
Real time alert setup for Omnicell Inc. performanceJuly 2025 Price Swings & Capital Protection Trading Alerts - newser.com
Ballad Health, Omnicell unveil three new IVX Station robots - WJHL
Is Omnicell Inc OC9 a good long term investmentOptions Trading Strategies & Accelerated Earnings Growth - earlytimes.in
1 Stock Under $50 with Promising Prospects and 2 Facing Challenges - The Globe and Mail
Omnicell Gains 41.6% in a Year: What's Driving the Stock? - MSN
Omnicell Inc Stock (OMCL) Financials Data
Revenue
Net Income
Cash Flow
EPS
8.35%
1.76%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):